Figure 6
From: Expression profiling of DNA methylation-mediated epigenetic gene-silencing factors in breast cancer
Immunohistochemical analysis of the DNMT1, DNMT3A, and DNMT3B expression (20 X and 40 X magnifications). (A) DNMT1, DNMT3A, and DNMT3B expression in primary breast cancer tissue samples. (B) DNMT1, DNMT3A, and DNMT3B expression in metastatic stage FFPE tissues shows higher protein expression (arrow) in comparison to primary stage. DNMT1 shows relatively higher expression than DNMT3A and DNMT3B in metastatic stage.